𝔖 Bobbio Scriptorium
✦   LIBER   ✦

No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer

✍ Scribed by Sigrid V. Carlsson; Erik Holmberg; Sue M. Moss; Monique J. Roobol; Fritz H. Schröder; Teuvo L.J. Tammela; Gunnar Aus; Anssi P. Auvinen; Jonas Hugosson

Book ID
110923226
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
298 KB
Volume
107
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection rates of high-grade prostate c
Detection rates of high-grade prostate cancer during subsequent screening visits. Results of the European Randomized Screening Study for Prostate Cancer
✍ Theodorus H. van der Kwast; Stefano Ciatto; Paula M. Martikainen; Robert Hoedema 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 137 KB 👁 1 views

## Abstract Screening for prostate cancer using prostate‐specific antigen (PSA) tests has led to a stage and grade shift as compared to the pre‐PSA era. Effectiveness of screening for prostate cancer should be manifested by a reduction in detection rate of aggressive cancers during subsequent scree

The European randomized study of screeni
The European randomized study of screening for prostate cancer : An update
✍ Bo Standaert; Louis Denis 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Background: A consensus meeting on screening and global strategy for prostate carcinoma, held in antwerp in 1994, determined the willingness among european cancer prevention centers to pursue vigorously the collaborative formation of a multinational randomized screening trial. this trial was to

PSA doubling time predicts the outcome a
PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section
✍ Khatami Ali; Aus Gunnar; Damber Jan-Erik; Lilja Hans; Lodding Pär; Hugosson Jona 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB 👁 2 views

## Abstract This study reports the outcome of active surveillance in men with PSA screening‐detected prostate cancer (PC), and PSA doubling time (PSADT) was evaluated as a predictor of selecting patients to active treatment or surveillance. On December 31, 1994, 10,000 men were randomized to bienni

Predictors for biopsy outcome in the Eur
Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam Region)
✍ Kranse, Ries; Beemsterboer, Petra; Rietbergen, John; Habbema, Dik; Hugosson, Jon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

In the European Randomized Study of Screening for Prostate Cancer (ER-SPC, Rotterdam region), men aged 55-74 years are screened for prostate cancer by prostatespecific antigen (PSA) sampling, digital rectal examination (DRE), and transrectal ultrasound investigation (TRUS). All men with a PSA Ն4 ng/